Travere Therapeutics (TVTX) Exchange Rate Effect (2014 - 2026)
Travere Therapeutics' (TVTX) quarterly Exchange Rate Effect came in at -$60000.0 in Q1 2026, down 110.95% YoY from $548000.0 in Q1 2025, and up 85.47% on a QoQ basis from -$413000.0 in Q4 2025.
Travere Therapeutics (TVTX) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Travere Therapeutics (TVTX) has 13 years of Exchange Rate Effect data on file, last reported at -$60000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 110.95% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (up 2437.5% YoY) and the FY2025 annual result came in at $2.3 million, up 350.93% from the prior year.
- Exchange Rate Effect climbed to -$60000.0 in Q1 2026, from -$413000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.9 million in Q2 2025 to a low of -$1.7 million in Q2 2022.
- A 5-year average of $29705.9 and a median of -$60000.0 in 2026 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect slumped 3085.71% — and 2025, when it soared 1888.07%.
- Tracing TVTX's Exchange Rate Effect over 5 years: stood at $1.1 million in 2022, then increased by 7.89% to $1.2 million in 2023, then sank by 178.31% to -$964000.0 in 2024, then soared by 57.16% to -$413000.0 in 2025, then soared by 85.47% to -$60000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$60000.0 (Q1 2026), -$413000.0 (Q4 2025), and $207000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Travere Therapeutics | 5.85 Bn | 5.85 Bn | 162.52 Mn | 72,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72,000.00 |
| Jun 30, 2026 | 72,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | -413,000.00 |
| Dec 31, 2025 | -413,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Sep 30, 2025 | 207,000.00 |
| Jun 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 548,000.00 |
| Mar 31, 2025 | 548,000.00 |
| Dec 31, 2024 | -964,000.00 |
| Dec 31, 2024 | -964,000.00 |
| Sep 30, 2024 | 453,000.00 |
| Sep 30, 2024 | 453,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Jun 30, 2024 | -109,000.00 |
| Mar 31, 2024 | -293,000.00 |
| Mar 31, 2024 | -293,000.00 |